Local arginase inhibition does not modulate cutaneous vasodilation or sweating in young and older men during exercise

Robert D. Meade, Naoto Fujii, Gregory W. McGarr, Lacy Marie Alexander, Pierre Boulay, Ronald J. Sigal, Glen P. Kenny

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Age-related impairments in cutaneous vascular conductance (CVC) and sweat rate (SR) during exercise may result from increased arginase activity, which can attenuate endogenous nitric oxide (NO) production. We therefore evaluated whether arginase inhibition modulates these heat-loss responses in young (n 9, 23 3 yr) and older (n 9, 66 6 yr) men during two 30-min bouts of moderate-intensity cycling (Ex1 and Ex2) in the heat (35°C). CVC and SR were measured at forearm skin sites perfused with 1) lactated Ringer’s (control), 2) NG-nitro-L-arginine methyl ester (L-NAME; NO synthase-inhibited), or 3) N-hydroxy-nor-arginine and S-(2-boronoethyl)-L-cysteine (Nor-NOHA BEC; arginase-inhibited). In both groups, CVC was reduced at L-NAME relative to control and Nor-NOHA BEC (both P 0.01). Likewise, SR was attenuated with L-NAME compared with control and Nor-NOHA BEC during each exercise bout in the young men (all P 0.05); however, no influence of treatment on SR in the older men was observed (P 0.14). Based on these findings, we then evaluated responses in 7 older men (64 7 yr) during passively induced elevations in esophageal temperature (Tes) equal to those in Ex1 (0.6°C) and Ex2 (0.8°C). L-NAME reduced CVC by 18 20% CVCmax at a Tes of 0.8°C (P 0.03) compared with control, whereas Nor-NOHA BEC augmented CVC by 20 18% CVCmax, on average, throughout heating (both P 0.03). SR was not influenced by either treatment (P 0.80) Thus, arginase inhibition does not modulate CVC or SR during exercise in the heat but, consistent with previous findings, does augment CVC in older men during passive heating.

Original languageEnglish (US)
Pages (from-to)1129-1137
Number of pages9
JournalJournal of Applied Physiology
Volume126
Issue number4
DOIs
StatePublished - Jan 1 2019

Fingerprint

Arginase
Sweating
Vasodilation
Sweat
Blood Vessels
Exercise
NG-Nitroarginine Methyl Ester
Skin
Hot Temperature
Heating
Forearm
Nitric Oxide Synthase
Arginine
Nitric Oxide
Temperature
Therapeutics

All Science Journal Classification (ASJC) codes

  • Physiology
  • Physiology (medical)

Cite this

Meade, Robert D. ; Fujii, Naoto ; McGarr, Gregory W. ; Alexander, Lacy Marie ; Boulay, Pierre ; Sigal, Ronald J. ; Kenny, Glen P. / Local arginase inhibition does not modulate cutaneous vasodilation or sweating in young and older men during exercise. In: Journal of Applied Physiology. 2019 ; Vol. 126, No. 4. pp. 1129-1137.
@article{6308dcc480724345aa021721e9596138,
title = "Local arginase inhibition does not modulate cutaneous vasodilation or sweating in young and older men during exercise",
abstract = "Age-related impairments in cutaneous vascular conductance (CVC) and sweat rate (SR) during exercise may result from increased arginase activity, which can attenuate endogenous nitric oxide (NO) production. We therefore evaluated whether arginase inhibition modulates these heat-loss responses in young (n 9, 23 3 yr) and older (n 9, 66 6 yr) men during two 30-min bouts of moderate-intensity cycling (Ex1 and Ex2) in the heat (35°C). CVC and SR were measured at forearm skin sites perfused with 1) lactated Ringer’s (control), 2) NG-nitro-L-arginine methyl ester (L-NAME; NO synthase-inhibited), or 3) N-hydroxy-nor-arginine and S-(2-boronoethyl)-L-cysteine (Nor-NOHA BEC; arginase-inhibited). In both groups, CVC was reduced at L-NAME relative to control and Nor-NOHA BEC (both P 0.01). Likewise, SR was attenuated with L-NAME compared with control and Nor-NOHA BEC during each exercise bout in the young men (all P 0.05); however, no influence of treatment on SR in the older men was observed (P 0.14). Based on these findings, we then evaluated responses in 7 older men (64 7 yr) during passively induced elevations in esophageal temperature (Tes) equal to those in Ex1 (0.6°C) and Ex2 (0.8°C). L-NAME reduced CVC by 18 20{\%} CVCmax at a Tes of 0.8°C (P 0.03) compared with control, whereas Nor-NOHA BEC augmented CVC by 20 18{\%} CVCmax, on average, throughout heating (both P 0.03). SR was not influenced by either treatment (P 0.80) Thus, arginase inhibition does not modulate CVC or SR during exercise in the heat but, consistent with previous findings, does augment CVC in older men during passive heating.",
author = "Meade, {Robert D.} and Naoto Fujii and McGarr, {Gregory W.} and Alexander, {Lacy Marie} and Pierre Boulay and Sigal, {Ronald J.} and Kenny, {Glen P.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1152/japplphysiol.00657.2018",
language = "English (US)",
volume = "126",
pages = "1129--1137",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "4",

}

Local arginase inhibition does not modulate cutaneous vasodilation or sweating in young and older men during exercise. / Meade, Robert D.; Fujii, Naoto; McGarr, Gregory W.; Alexander, Lacy Marie; Boulay, Pierre; Sigal, Ronald J.; Kenny, Glen P.

In: Journal of Applied Physiology, Vol. 126, No. 4, 01.01.2019, p. 1129-1137.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Local arginase inhibition does not modulate cutaneous vasodilation or sweating in young and older men during exercise

AU - Meade, Robert D.

AU - Fujii, Naoto

AU - McGarr, Gregory W.

AU - Alexander, Lacy Marie

AU - Boulay, Pierre

AU - Sigal, Ronald J.

AU - Kenny, Glen P.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Age-related impairments in cutaneous vascular conductance (CVC) and sweat rate (SR) during exercise may result from increased arginase activity, which can attenuate endogenous nitric oxide (NO) production. We therefore evaluated whether arginase inhibition modulates these heat-loss responses in young (n 9, 23 3 yr) and older (n 9, 66 6 yr) men during two 30-min bouts of moderate-intensity cycling (Ex1 and Ex2) in the heat (35°C). CVC and SR were measured at forearm skin sites perfused with 1) lactated Ringer’s (control), 2) NG-nitro-L-arginine methyl ester (L-NAME; NO synthase-inhibited), or 3) N-hydroxy-nor-arginine and S-(2-boronoethyl)-L-cysteine (Nor-NOHA BEC; arginase-inhibited). In both groups, CVC was reduced at L-NAME relative to control and Nor-NOHA BEC (both P 0.01). Likewise, SR was attenuated with L-NAME compared with control and Nor-NOHA BEC during each exercise bout in the young men (all P 0.05); however, no influence of treatment on SR in the older men was observed (P 0.14). Based on these findings, we then evaluated responses in 7 older men (64 7 yr) during passively induced elevations in esophageal temperature (Tes) equal to those in Ex1 (0.6°C) and Ex2 (0.8°C). L-NAME reduced CVC by 18 20% CVCmax at a Tes of 0.8°C (P 0.03) compared with control, whereas Nor-NOHA BEC augmented CVC by 20 18% CVCmax, on average, throughout heating (both P 0.03). SR was not influenced by either treatment (P 0.80) Thus, arginase inhibition does not modulate CVC or SR during exercise in the heat but, consistent with previous findings, does augment CVC in older men during passive heating.

AB - Age-related impairments in cutaneous vascular conductance (CVC) and sweat rate (SR) during exercise may result from increased arginase activity, which can attenuate endogenous nitric oxide (NO) production. We therefore evaluated whether arginase inhibition modulates these heat-loss responses in young (n 9, 23 3 yr) and older (n 9, 66 6 yr) men during two 30-min bouts of moderate-intensity cycling (Ex1 and Ex2) in the heat (35°C). CVC and SR were measured at forearm skin sites perfused with 1) lactated Ringer’s (control), 2) NG-nitro-L-arginine methyl ester (L-NAME; NO synthase-inhibited), or 3) N-hydroxy-nor-arginine and S-(2-boronoethyl)-L-cysteine (Nor-NOHA BEC; arginase-inhibited). In both groups, CVC was reduced at L-NAME relative to control and Nor-NOHA BEC (both P 0.01). Likewise, SR was attenuated with L-NAME compared with control and Nor-NOHA BEC during each exercise bout in the young men (all P 0.05); however, no influence of treatment on SR in the older men was observed (P 0.14). Based on these findings, we then evaluated responses in 7 older men (64 7 yr) during passively induced elevations in esophageal temperature (Tes) equal to those in Ex1 (0.6°C) and Ex2 (0.8°C). L-NAME reduced CVC by 18 20% CVCmax at a Tes of 0.8°C (P 0.03) compared with control, whereas Nor-NOHA BEC augmented CVC by 20 18% CVCmax, on average, throughout heating (both P 0.03). SR was not influenced by either treatment (P 0.80) Thus, arginase inhibition does not modulate CVC or SR during exercise in the heat but, consistent with previous findings, does augment CVC in older men during passive heating.

UR - http://www.scopus.com/inward/record.url?scp=85065028101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065028101&partnerID=8YFLogxK

U2 - 10.1152/japplphysiol.00657.2018

DO - 10.1152/japplphysiol.00657.2018

M3 - Article

C2 - 30653418

AN - SCOPUS:85065028101

VL - 126

SP - 1129

EP - 1137

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 4

ER -